C. difficile Diarrhea Flashcards
What are the risk factors for CDAD? (9)
1) Advanced age > 65 years
2) Multiple or severe comorbidities
3) Immuno suppression
4) History of CDI
5) GI surgery (affects ecology of GIT)
6) Tube feeding (may affect ecology of GIT)
7) Increased healthcare exposure (↑ risk of colonisation) e.g
- Prior hospitalization (last 1 year)
- ↑ Duration of hospitalization
- Residence in nursing home or long‐term care facilities
8) Use of antibiotics (e.g ↑ dose, days of treatment or number of antibiotics + differs between class used also; risk highest when receiving antibiotics but risk remains elevated up to 12 weeks after stopping)
9) Use of gastric acid suppressive therapy (e.g PPI; changes pH in colon and affect ecology)
Which antibiotics haeve the greatest risk of causing CDAD?
1) Clindamycin (Odds Ratio 16.80)
2) Third‐ and fourth‐generation cephalosporins (OR 5.68)
3) Fluoroquinolones (OR 5.50)
usually those that have gram negative and anaerobe coverage -> more able to destroy the usual bacteria in the GIT; mostly broad spectrum except Clindamycin
Which antibiotics may have protective effects against CDAD?
Doxycycline/ tigecycline
What are the symptoms of fulminant CDAD?
1) Hypotension/shock
2) Ileus (cessation of gut motility with no sign of mechanical obstruction -> intolerant to oral intake)
3) Megacolon (very swollen colon)
4) Watery diarrhea (at least 3 loose stools within 24 hours)
What are the symptoms of severe CDAD?
1) Fever, diffused abdominal cramps and distension
2) WBC ≥ 15 x 10^9/L or Scr ≥ 133 μmol/L (1.5 mg/dL)
3) Diarrhea
What are the symptoms of moderate CDAD?
1) Fever, nausea, malaise
2) Abdominal cramps and distension
3) Leukocytosis (higher WBC)
4) Hypovolemia
5) Diarrhea
What are the requirements of diagnosis of CDAD?
Presence of diarrhea (3 unformed stools in 24 hours not due to laxative or GI disease), OR Radiographic evidence of ileus or toxic megacolon
AND
A positive stool test result for C difficile or its toxins, OR Colonoscopic or histopathologic evidence of pseudomembranous colitis
State what are the various stool tests, what they detect, and their limitations.
1) Nucleic acid amplification test (NAAT)
o Identifies genes that produces toxin A and B, does not differentiate if genes are activated and toxin is produced
2) Polymerase chain reaction (PCR)
o Identifies genes that produces toxin A and B, does not differentiate if genes are activated and toxin is produced
3) Enzyme immunoassay (EIA) toxins A and B
o But doesn’t pick it up very well so cannot be used as sole diagnostic yet
4) Glutamate dehydrogenase (GDH) immunoassay (least favoured)
o Identifies all forms of C. Diff but does not differentiate between non-toxic from toxic strains
State the possible treatment regimen for this patient with first initial episode of CDAD.
[WBC < 15 x 10^9/L AND Scr < 133 μmol/L
(1.5 mg/dL)]
First Line:
- *PO Fidaxomicin 200mg BD
- PO Vancomycin 125mg QDS
Alternative:
- PO Metronidazole 400mg TDS
Duration: 10 days, may extend to 14 days if symptoms not completely resolved
State the possible treatment regimen for this patient with first initial episode of CDAD.
[WBC ≥ 15 x 109/L OR Scr ≥ 133 μmol/L
(1.5 mg/dL)]
First Line:
- *PO Fidaxomicin 200mg BD
- PO Vancomycin 125mg QDS
Duration: 10-14 days
State the possible treatment regimen for this patient with first initial episode of CDAD.
Symptoms: Hypotension OR ileus OR megacolon
IV Metronidazole 500mg Q8H + PO Vancomycin 500mg QDS +/- PR Vancomycin 500mg QDS
Duration: 10-14 days
Note: IV Metro can undergo enterohepatic circulation (EHC) so some still can get to GIT but IV Vanco cannot undergo EHC.
What are the treatment principles of CDAD?
1) Do not treat asymptomatic patients with a positive C. difficile test
* Confirm symptoms consistent with CDI exist prior to prescribing therapy
2) If possible, discontinue any antibiotic therapy not specifically treating CDI
3) If additional antibiotic therapy is necessary:
* Select the narrowest agent possible
* Avoid agents with a strong association with CDI
* Consider a tetracycline if appropriate (protective effect)
What are risk factors for recurrent CDAD? (4)
1) Administration of other antibiotics during or after initial treatment of CDI
2) A defective humoral immune response against C. difficile toxins
3) Advancing age and severe underlying disease (may have defective immune response also)
4) Continued use of PPIs
State when stool test should/should not be conducted
SHOULD
- Confirm that patient has not received laxative within prior 48hr
- Only performed for symptomatic patients (asymptomatic colonisers don’t need treatment)
SHOULD NOT
- Repeat testing in < 7 days (CDAD will continue to be present for a few days)
- Repeat to document cure (most patients with favourable clinical responses continue to test positive)
State the possible regimens for a patient with first recurrence of CDAD who was on Fidaxomicin/ Vancomycin for initial episode. (no need give the pulse dosing)
- PO Fidaxomicin 200mg BD x 10 days
- PO Fidaxomicin 200mg (pulsed)
- PO Vancomycin tapered/pulsed